Skip to main content

RenovoRx, Inc.

RNXT
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001574094

In the last 90 days, RenovoRx, Inc. insiders filed 1 open-market purchase and 0 sales; 40 institutions reported holding it in 13F filings for Q3 2026, worth $19.1M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by RenovoRx, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
1 filing
1 insider, $46.5K in total
Open-market sells
0 filings
Insiders trading
1
Net value
+$46.5K
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for RenovoRx, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for RenovoRx, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Agah RamtinExecutive Chairman and CMO848,460Nov 17, 20268
Macfarlane Kirsten AngelaDirector40,983Oct 2, 20261
Spiegel Robert J.Director40,983Oct 2, 20261
Ryan Una SDirector97,165IndirectOct 2, 20262
Marton LaurenceDirector9,720IndirectOct 2, 20262
Voll MarkChief Financial Officer222,380Sep 15, 20265
Bagai ShaunChief Executive Officer313,357IndirectApr 7, 20264
Gentry LeesaChief Clinical Officer–Apr 7, 20261
Kocak RonVP, Controller and PAO12,595Jul 3, 20250
Nelms AngelaChief Operating Officer1,100Jan 23, 20240
Diamond DavidDirector–Oct 2, 20230

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 17, 2026 (view filing)6:30 AM ETNov 161 dayAgah RamtinExecutive Chairman and CMOPPurchase+50.0K$0.9297+$46.5K+6.3%848.5K after
May 21, 2026 (view filing)May 192 daysVoll MarkChief Financial OfficerPPurchase+25.0K$0.79+$19.8K+21.3%142.4K after
Mar 24, 2026 (view filing)Mar 204 daysMarton LaurenceDirectorPPurchase+9.72K––New position9.72K after
Mar 24, 2026 (view filing)Mar 204 daysMarton LaurenceDirectorPPurchase+4.86K–––4.86K afterDerivative
Mar 24, 2026 (view filing)Mar 204 daysBagai ShaunChief Executive OfficerPPurchase+24.3K––+8.4%313.4K after
Mar 24, 2026 (view filing)Mar 204 daysBagai ShaunChief Executive OfficerPPurchase+12.2K–––12.2K afterDerivative
Mar 24, 2026 (view filing)Mar 204 daysVoll MarkChief Financial OfficerPPurchase+97.2K––New position97.2K after
Mar 24, 2026 (view filing)Mar 204 daysVoll MarkChief Financial OfficerPPurchase+48.6K–––48.6K afterDerivative
Jan 22, 2026 (view filing)Jan 211 dayAgah RamtinChief Medical OfficerPPurchase+10.0K$1.00+$10.0K+1.3%798.5K after
Jan 5, 2026 (view filing)Dec 31, 20255 daysAgah RamtinChief Medical OfficerPPurchase+9.79K$0.86+$8.42K+1.3%788.5K after
Jan 2, 2026 (view filing)Dec 30, 20253 daysAgah RamtinChief Medical OfficerPPurchase+205$0.83+$170.150.0%778.7K after
Dec 22, 2025 (view filing)Dec 184 daysBagai ShaunChief Executive OfficerPPurchase+5.00K$0.90+$4.50K+1.5%340.0K after
Dec 19, 2025 (view filing)Dec 172 daysBagai ShaunChief Executive OfficerPPurchase+5.00K$0.85+$4.25K+1.5%335.0K after
Dec 17, 2025 (view filing)Dec 161 dayAgah RamtinChief Medical OfficerPPurchase+12.0K$0.85+$10.2K+1.6%778.5K after
Dec 8, 2025 (view filing)Dec 53 daysAgah RamtinChief Medical OfficerPPurchase+10.0K$0.96+$9.60K+1.3%766.5K after
Nov 24, 2025 (view filing)Nov 21-243 daysAgah RamtinChief Medical OfficerPPurchase+22.0K$0.80+$17.6K+3.0%756.5K after2 lots
Aug 26, 2025 (view filing)Aug 22-254 daysBagai ShaunChief Executive OfficerPPurchase+10.0K$0.93+$9.30K+3.1%330.0K after2 lots
Jun 9, 2025 (view filing)Jun 54 daysAgah RamtinChief Medical OfficerPPurchase+21.0K$1.40+$29.4K+2.9%734.5K after
Apr 17, 2025 (view filing)Apr 152 daysAgah RamtinChief Medical OfficerPPurchase+15.0K$0.90+$13.5K+1.4%1.11M after
Apr 16, 2025 (view filing)Apr 151 dayBagai ShaunChief Executive OfficerPPurchase+7.50K$0.91+$6.83K+2.4%320.0K after
Apr 14, 2025 (view filing)Apr 113 daysAgah RamtinChief Medical OfficerPPurchase+20.0K$0.80+$16.0K+1.9%1.10M after
Apr 10, 2025 (view filing)Apr 8-102 daysKocak RonVP Controller and PAOPPurchase+12.6K$0.7948+$10.0KNew position12.6K after3 lots
Apr 10, 2025 (view filing)Apr 91 dayAgah RamtinChief Medical OfficerPPurchase+30.0K$0.81+$24.3K+2.9%1.08M after
Apr 10, 2025 (view filing)Apr 91 dayBagai ShaunChief Executive OfficerPPurchase+10.0K$0.83+$8.30K+3.3%312.5K after
Apr 9, 2025 (view filing)Apr 81 dayMarton LaurenceDirectorPPurchase+12.1K$0.85+$10.2K+35.8%45.7K after
Apr 9, 2025 (view filing)Apr 81 dayAgah RamtinChief Medical OfficerPPurchase+26.0K$0.84+$21.8K+2.5%1.05M after
Apr 8, 2025 (view filing)Apr 71 dayBagai ShaunChief Executive OfficerPPurchase+10.0K$0.83+$8.30K+3.4%302.5K after
Jan 30, 2024 (view filing)Jan 264 daysAgah RamtinChief Medical OfficerPPurchase+41.0K––+632.7%47.5K after
Jan 30, 2024 (view filing)Jan 264 daysAgah RamtinChief Medical OfficerPPurchase+41.0K–––41.0K afterDerivative
Jan 30, 2024 (view filing)Jan 264 daysSpiegel Robert J.DirectorPPurchase+41.0K––New position41.0K after
Jan 30, 2024 (view filing)Jan 264 daysSpiegel Robert J.DirectorPPurchase+41.0K–––41.0K afterDerivative
Jan 30, 2024 (view filing)Jan 264 daysBagai ShaunChief Executive OfficerPPurchase+41.0K––+16.3%292.5K after
Jan 30, 2024 (view filing)Jan 264 daysBagai ShaunChief Executive OfficerPPurchase+41.0K–––41.0K afterDerivative
Jan 30, 2024 (view filing)Jan 264 daysMarton LaurenceDirectorPPurchase+8.20K––+32.2%33.6K after
Jan 30, 2024 (view filing)Jan 264 daysMarton LaurenceDirectorPPurchase+8.20K–––8.20K afterDerivative
Jan 30, 2024 (view filing)Jan 264 daysMacfarlane Kirsten AngelaDirectorPPurchase+41.0K––New position41.0K after
Jan 30, 2024 (view filing)Jan 264 daysMacfarlane Kirsten AngelaDirectorPPurchase+41.0K–––41.0K afterDerivative
Oct 4, 2023 (view filing)Oct 31 dayNelms AngelaChief Operating OfficerPPurchase+1.10K$1.05+$1.16KNew position1.10K after2 lots
Jun 9, 2022 (view filing)Jun 72 daysAgah RamtinChief Medical OfficerPPurchase+5.18K$1.93+$10.0K+400.2%6.48K after
May 23, 2022 (view filing)May 194 daysBagai ShaunChief Executive OfficerPPurchase+5.50K$2.05+$11.3K+2.2%251.6K after